Free Trial

Cardlytics (CDLX) News Today

$9.00
-0.20 (-2.17%)
(As of 10:39 AM ET)
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 43,129 Shares of Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Karim Saad Temsamani sold 43,129 shares of the business's stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $8.65, for a total transaction of $373,065.85. Following the transaction, the chief executive officer now directly owns 385,530 shares of the company's stock, valued at approximately $3,334,834.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Cardlytics, Inc. (NASDAQ:CDLX) Sees Significant Increase in Short Interest
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 6,550,000 shares, a growth of 17.0% from the April 30th total of 5,600,000 shares. Based on an average daily volume of 1,860,000 shares, the short-interest ratio is presently 3.5 days.
5 Best Marketing Stocks to Buy
Craig Hallum Cuts Cardlytics (NASDAQ:CDLX) Price Target to $12.00
Craig Hallum cut their price target on Cardlytics from $18.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday.
Why Is Cardlytics (CDLX) Stock Down 29% Today?
Cardlytics: Q1 Earnings Snapshot
Cardlytics (CDLX) Scheduled to Post Earnings on Wednesday
Cardlytics (NASDAQ:CDLX) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=588904)
CDLX Jul 2024 9.000 put (CDLX240719P00009000)
Cardlytics executive sells over $3.5k in stock
Cardlytics, Inc. (NASDAQ:CDLX) COO Sells $278,884.56 in Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) COO Amit Gupta sold 23,416 shares of the company's stock in a transaction dated Wednesday, April 24th. The stock was sold at an average price of $11.91, for a total transaction of $278,884.56. Following the completion of the transaction, the chief operating officer now owns 122,676 shares in the company, valued at $1,461,071.16. The sale was disclosed in a filing with the SEC, which is available through this link.
Cardlytics, Inc. (CDLX)
Vanguard Group Inc. Boosts Stake in Cardlytics, Inc. (NASDAQ:CDLX)
Vanguard Group Inc. boosted its position in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 13.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,011,705 shares of the company's stock after buying a
Cardlytics (NASDAQ:CDLX) Trading 4.7% Higher
Cardlytics (NASDAQ:CDLX) Stock Price Up 4.7%
Baillie Gifford & Co. Cuts Stake in Cardlytics, Inc. (NASDAQ:CDLX)
Baillie Gifford & Co. cut its position in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 9.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 946,058 shares of the company's stock after selling 103,390 shares during the period. Baillie Gifford & Co. owned a
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
Cardlytics (NASDAQ:CDLX) Price Target Increased to $17.00 by Analysts at Needham & Company LLC
Needham & Company LLC boosted their price target on Cardlytics from $15.00 to $17.00 and gave the company a "buy" rating in a research report on Tuesday.
Assenagon Asset Management S.A. Buys 82,152 Shares of Cardlytics, Inc. (NASDAQ:CDLX)
Assenagon Asset Management S.A. boosted its stake in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 540.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,351 shares of the company's stock after acquiring an
Craig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)
Cardlytics (NASDAQ:CDLX) Shares Up 5.3%
Cardlytics (NASDAQ:CDLX) Trading Up 5.3%
Cardlytics (NASDAQ:CDLX) Shares Down 3.7% on Insider Selling
Cardlytics (NASDAQ:CDLX) Stock Price Down 3.7% on Insider Selling
Nicholas Hollmeyer Lynton Sells 12,460 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 12,460 shares of the business's stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total transaction of $170,577.40. Following the completion of the transaction, the insider now directly owns 71,355 shares of the company's stock, valued at $976,849.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Cardlytics (NASDAQ:CDLX) Shares Down 4.4%
Cardlytics (NASDAQ:CDLX) Shares Down 4.4%
Cardlytics (NASDAQ:CDLX) Sees Unusually-High Trading Volume
Cardlytics (NASDAQ:CDLX) Sees Strong Trading Volume
Why Cardlytics (CDLX) Stock Is Down 30%

CDLX Media Mentions By Week

CDLX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CDLX
News Sentiment

1.00

0.86

Average
Business Services
News Sentiment

CDLX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CDLX Articles
This Week

3

3

CDLX Articles
Average Week

Get Cardlytics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CDLX) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners